

Yuri is a longevity biotech entrepreneur specializing in early-stage translation of scientific breakthroughs into therapies, particularly in the CNS space: previously, Yuri has led several early-stage pharmaceutical startups, including one developing an Alzheimer's therapeutic, and another developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease. Currently, Yuri is leading YouthBio Therapeutics, which is developing epigenetic rejuvenation gene therapies based on partial cellular reprogramming by Yamanaka factors.

Related Organizations

Articles from this author

September 17, 2025

Lifespan Research Institute Launches Public Longevity Group

[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...